Atlas Trials

18F-Flutemetamol and Plaque Vulnerability

Clinical trial NCT03291093 · UNKNOWN

Trial details

NCT number
NCT03291093
Sponsor
Maastricht University Medical Center
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2018-02-01
Primary completion
2019-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.